ADMA Biologics Inc (NASDAQ:ADMA)

5.38
Delayed Data
As of 4:00pm ET
 +0.20 / +3.86%
Today’s Change
2.01
Today|||52-Week Range
5.70
+67.60%
Year-to-Date
No recent news for ADMA Biologics Inc.

Today’s Trading

Previous close5.18
Today’s open5.22
Day’s range5.14 - 5.59
Volume232,250
Average volume (3 months)124,413
Market cap$238.4M
Data as of 4:00pm ET, 05/22/2018

Growth & Valuation

Earnings growth (last year)-18.63%
Earnings growth (this year)+42.15%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+113.49%
P/E ratioNM
Price/Sales3.23
Price/Book5.91

Competitors

 Today’s
change
Today’s
% change
SRRASierra Oncology Inc-0.20-7.78%
CFRXContraFect Corp-0.05-2.65%
CYTRCytRx Corp+0.02+1.53%
PFNXPfenex Inc-0.01-0.14%
Data as of 4:10pm ET, 05/22/2018

Financials

Next reporting dateAugust 13, 2018
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$22.8M
Annual profit (last year)-$43.8M
Net profit margin-192.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Adam S. Grossman
Chief Financial &
Principal Accounting Officer, VP
Brian Lenz
Corporate headquarters
Ramsey, New Jersey

Forecasts